LMTK2 and benign prostatic hyperplasia: We measured the total or isoform specific gene expression of the JAZF1 (JAZF zinc finger 1), CTBP2 (C-terminal binding protein 2), LMTK2 (lemur tyrosine kinase 2), SLC22A3 (solute carrier family 22 extraneuronal monoamine transporter, member 3), MYEOV (myeloma overexpressed), MSMB (microseminoprotein beta) and HNF1B (HNF homeobox 1 beta) in a cohort of 39 non-malignant benign prostatic hyperplasia (BPH) samples and 21 prostate adenocarcinoma samples, and correlated gene expression with cancer status and with the genetic variants identified in the GWAS (table 1).